Cassava Sciences INC (FLNA) SEC Filings — 2024
31 SEC filings for Cassava Sciences INC (FLNA) in 2024.
Filings
- Cassava Sciences Files 8-K — 8-K · Nov 25, 2024
- Cassava Sciences Files 8-K on Financials — 8-K · Nov 7, 2024
- Cassava Sciences Reports $0 Revenue, Increased Expenses — 10-Q · Nov 7, 2024
- Cassava Sciences INC SC 13G/A Filing — SC 13G/A · Nov 4, 2024
- Cassava Sciences Files 8-K — 8-K · Oct 8, 2024
- Cassava Sciences amends 8-K, Officer Changes — 8-K/A · Oct 1, 2024
- Cassava Sciences Files 8-K — 8-K · Sep 27, 2024
- Cassava Sciences Files 8-K for Financials — 8-K · Sep 17, 2024
- Cassava Sciences Board Shake-up: New Director Appointed, One Departs — 8-K · Sep 9, 2024
- Cassava Sciences Files 8-K/A Amendment — 8-K/A · Aug 9, 2024
- Cassava Sciences Files 8-K on Financials and Listing Status — 8-K · Aug 8, 2024
- Cassava Sciences Q2 2024: Cash Up, Equity Down — 10-Q · Aug 8, 2024
- Cassava Sciences Files 8-K — 8-K · Jul 22, 2024
- Cassava Sciences Issues Shares from Warrant Exercise — 8-K · Jul 18, 2024
- Cassava Sciences Files 8-K: Director Changes & Officer Compensation Updates — 8-K · Jul 17, 2024
- Cassava Sciences Updates Business Address — 8-K · Jul 1, 2024
- Cassava Sciences Appoints New CMO, Adds Directors — 8-K · May 22, 2024
- Cassava Sciences Files 8-K on Shareholder Votes and Financials — 8-K · May 13, 2024
- Cassava Sciences Files 8-K on Financials — 8-K · May 10, 2024
- Cassava Sciences Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 10, 2024
- Cassava Sciences Appoints New Chief Medical Officer — 8-K · May 8, 2024
- Cassava Sciences Files 8-K — 8-K · May 1, 2024
- Cassava Sciences Files 8-K — 8-K · Apr 15, 2024
- Cassava Sciences Files Definitive Proxy Statement — DEF 14A · Mar 26, 2024
- Cassava Sciences Files 8-K on Financial Condition — 8-K · Feb 28, 2024
- Cassava Sciences Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 28, 2024
- Cassava Sciences INC SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Cassava Sciences Files Routine 8-K, Confirms NASDAQ Listing — 8-K · Feb 7, 2024
- Cassava Sciences CEO Remi Barbier Maintains Significant SAVA Stake — SC 13G/A · Feb 1, 2024
- BlackRock Amends Cassava Sciences Stake as of Dec 31, 2023 — SC 13G/A · Jan 26, 2024
- Cassava Sciences Reports Material Definitive Agreement on Jan 3 — 8-K · Jan 3, 2024